given as a subcutaneous injection. Dupixent is a biologic and belongs to a drug class called interleukin-4 (IL-4) receptor blockers. The medication is not available in a biosimilar version.

For an in-depth look and details about the drug’s uses, see this Dupixent overview article. Dupixent pen and Dupixent syringe are used to give Dupixent doses by subcutaneous injection.

Drugs like Dupixent for eczema fall into this category ... If you’re about to get an injection, infusion, or procedure done in a hospital system, ask ahead of time for an estimate of what ...

These drugs inhibit interleukin (IL)-5, while Dupixent inhibits IL-4 and IL-13, but can be considered a rival because it is also an injection. Patients may opt to take the others because of their ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

Sanofi has upped its revenue forecasts for the year on the back of strong second quarter results from its new eczema and asthma injection Dupixent and ... So far the drug has been launched in ...

This achievement further emphasises the drug’s efficacy across multiple indications, including atopic dermatitis (AD), in which it is considered the gold standard. The use of Dupixent in AD has ...